Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: a systematic review.

Seitz DP, Brisbin S, Herrmann N, Rapoport MJ, Wilson K, Gill SS, Rines J, Le Clair K, Conn D.

J Am Med Dir Assoc. 2012 Jul;13(6):503-506.e2. doi: 10.1016/j.jamda.2011.12.059. Epub 2012 Feb 17. Review.

PMID:
22342481
2.

What are the barriers to performing nonpharmacological interventions for behavioral symptoms in the nursing home?

Cohen-Mansfield J, Thein K, Marx MS, Dakheel-Ali M.

J Am Med Dir Assoc. 2012 May;13(4):400-5. doi: 10.1016/j.jamda.2011.07.006. Epub 2011 Aug 26.

3.

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.

Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS; Alzheimer's Disease Cooperative Study Group.

Arch Gen Psychiatry. 2011 Aug;68(8):853-61. doi: 10.1001/archgenpsychiatry.2011.72.

PMID:
21810649
4.

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Tariot PN, Zheng L, Schneider LS.

Am J Psychiatry. 2011 Aug;168(8):831-9. doi: 10.1176/appi.ajp.2011.08121844. Epub 2011 May 15.

5.

Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study.

Barak Y, Plopski I, Tadger S, Paleacu D.

Int Psychogeriatr. 2011 Nov;23(9):1515-9. doi: 10.1017/S1041610211000743. Epub 2011 Apr 15.

PMID:
21492498
6.

Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.

Huybrechts KF, Rothman KJ, Silliman RA, Brookhart MA, Schneeweiss S.

CMAJ. 2011 Apr 19;183(7):E411-9. doi: 10.1503/cmaj.101406. Epub 2011 Mar 28.

7.

Associated factors with antipsychotic use in assisted living facilities: a cross-sectional study of 4367 residents.

Larrayadieu A, Abellan van Kan G, Piau A, Soto Martin M, Nourhashemi F, Rolland Y, Vellas B.

Age Ageing. 2011 May;40(3):368-75. doi: 10.1093/ageing/afr032. Epub 2011 Mar 23.

PMID:
21429950
8.

Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries.

Snowdon J, Galanos D, Vaswani D.

Int Psychogeriatr. 2011 Nov;23(9):1520-5. doi: 10.1017/S1041610211000445. Epub 2011 Mar 24.

PMID:
21429281
9.

Association of cerebrovascular events with antidepressant use: a case-crossover study.

Wu CS, Wang SC, Cheng YC, Gau SS.

Am J Psychiatry. 2011 May;168(5):511-21. doi: 10.1176/appi.ajp.2010.10071064. Epub 2011 Mar 15.

PMID:
21406464
10.

Antidepressants for agitation and psychosis in dementia.

Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191. doi: 10.1002/14651858.CD008191.pub2. Review.

PMID:
21328305
11.

Trends in antipsychotic use in dementia 1999-2007.

Kales HC, Zivin K, Kim HM, Valenstein M, Chiang C, Ignacio RV, Ganoczy D, Cunningham F, Schneider LS, Blow FC.

Arch Gen Psychiatry. 2011 Feb;68(2):190-7. doi: 10.1001/archgenpsychiatry.2010.200. Erratum in: Arch Gen Psychiatry. 2011 May;68(5):466. Ignacio, Rosalindo [corrected to Ignacio, Rosalinda V].

PMID:
21300946
12.

Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.

Andrade C, Sandarsh S, Chethan KB, Nagesh KS.

J Clin Psychiatry. 2010 Dec;71(12):1565-75. doi: 10.4088/JCP.09r05786blu. Review.

PMID:
21190637
13.

Advances in the treatment of psychiatric disorders in long-term care homes.

Conn DK, Seitz DP.

Curr Opin Psychiatry. 2010 Nov;23(6):516-21. doi: 10.1097/YCO.0b013e32833efe56. Review.

PMID:
20838347
14.

Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review.

Seitz D, Purandare N, Conn D.

Int Psychogeriatr. 2010 Nov;22(7):1025-39. doi: 10.1017/S1041610210000608. Epub 2010 Jun 4. Review.

PMID:
20522279
15.

Risk of ischemic stroke associated with antidepressant drug use in elderly persons.

Trifirò G, Dieleman J, Sen EF, Gambassi G, Sturkenboom MC.

J Clin Psychopharmacol. 2010 Jun;30(3):252-8. doi: 10.1097/JCP.0b013e3181dca10a.

PMID:
20473059
16.

Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia.

Jalbert JJ, Eaton CB, Miller SC, Lapane KL.

J Am Med Dir Assoc. 2010 Feb;11(2):120-7. doi: 10.1016/j.jamda.2009.10.001. Epub 2010 Jan 12.

PMID:
20142067
17.

Management of behavioral problems in Alzheimer's disease.

Gauthier S, Cummings J, Ballard C, Brodaty H, Grossberg G, Robert P, Lyketsos C.

Int Psychogeriatr. 2010 May;22(3):346-72. doi: 10.1017/S1041610209991505. Epub 2010 Jan 25. Review.

PMID:
20096151
18.

Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.

Wang LY, Shofer JB, Rohde K, Hart KL, Hoff DJ, McFall YH, Raskind MA, Peskind ER.

Am J Geriatr Psychiatry. 2009 Sep;17(9):744-51. doi: 10.1097/JGP.0b013e3181ab8c61.

19.

Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.

Ballard C, Corbett A, Chitramohan R, Aarsland D.

Curr Opin Psychiatry. 2009 Nov;22(6):532-40. doi: 10.1097/YCO.0b013e32833111f9. Review.

PMID:
19696673
20.

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group.

PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097. Epub 2009 Jul 21. No abstract available.

Supplemental Content

Support Center